Clinical Trial Update: Administration of Fingolimod in Greek Patients With Multiple Sclerosis.

View source ↗

Summary

Clinical trial update indicates Fingolimod is to be administered in Greek patients with Relapsing Remitting Multiple Sclerosis, with the study status listed as …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Relapsing-remitting Multiple Sclerosis

Drugs mentioned

• Fingolimod (Gilenya) (fingolimod)

Snippet

Sponsor: Elpen Pharmaceutical Co. Inc. | Conditions: Relapsing Remitting Multiple Sclerosis | Status: NOT_YET_RECRUITING